BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND SEPT6, RP5-876A24_2, 23157, ENSG00000125354, Q14141, SEP2, MGC16619, KIAA0128, MGC20339
34604 results:

  • 1. Decomposing difference in the kidney cancer burden measures between 1990 and 2019 based on the global burden of disease study.
    Ayubi E; Shahbazi F; Khazaei S
    Sci Rep; 2024 May; 14(1):10390. PubMed ID: 38710935
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Contrast-Enhanced Ultrasound as a Diagnostic Procedure in Renal Diseases: A Case Report.
    Sellitto S; Tarantino L; Barone F; Barone N; Perna A; Lucariello A; Guerra G; De Luca A; Filippelli A; Sellitto C
    G Ital Nefrol; 2024 Apr; 41(2):. PubMed ID: 38695227
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Molecular and functional characterization of reversible-sunitinib-tolerance state in human renal cell carcinoma.
    Zaccagnino A; Vynnytska-Myronovska B; Stöckle M; Junker K
    J Cell Mol Med; 2024 May; 28(9):e18329. PubMed ID: 38693863
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Epidemiology, treatment and outcomes of primary renal sarcomas in adult patients.
    Uhlig J; Uhlig A; Deshpande H; Ströbel P; Trojan L; Lotz J; Hurwitz M; Hafez O; Humphrey P; Grünwald V; Kim HS
    Sci Rep; 2024 May; 14(1):10038. PubMed ID: 38693188
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A retrospective clinical analysis of 11 cases of PEComa from different sites.
    Yan J; Zhou D; Wang Y; Yang B; Wang Y; Zhang K; Zhang S; Zhang B; Meng Q; Lv Q
    World J Surg Oncol; 2024 Apr; 22(1):116. PubMed ID: 38689335
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Establishment and validation of a nomogram for predicting overall survival of upper-tract urothelial carcinoma with bone metastasis: a population-based study.
    Hu J; Gu H; Zhang D; Wen M; Yan Z; Song B; Xie C
    BMC Urol; 2024 Apr; 24(1):100. PubMed ID: 38689213
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. HECTD2/TNFAIP1 Axis Regulating the p38/JNK Pathway to Promote an Inflammatory Response in Renal Cell Carcinoma Cells.
    Lv D; Chen Y; Tang L; Tian Y; Ren D; Jian N; Shen T
    In Vivo; 2024; 38(3):1094-1103. PubMed ID: 38688591
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Area Vulnerability and Disparities in Therapy for Patients With Metastatic Renal Cell Carcinoma.
    Rahman SN; Long JB; Westvold SJ; Leapman MS; Spees LP; Hurwitz ME; McManus HD; Gross CP; Wheeler SB; Dinan MA
    JAMA Netw Open; 2024 Apr; 7(4):e248747. PubMed ID: 38687479
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Impact of hyperuricemia and chronic kidney disease on the prevalence and mortality of cardiovascular disease in cancer survivors.
    Chen Y; Chen Y; Lin W; Fu L; Liu H; Pu S; Chen H; Yi H; Xue Y
    Cancer Med; 2024 May; 13(9):e7180. PubMed ID: 38686569
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Identifying therapeutic targets for cancer among 2074 circulating proteins and risk of nine cancers.
    Smith-Byrne K; Hedman Å; Dimitriou M; Desai T; Sokolov AV; Schioth HB; Koprulu M; Pietzner M; Langenberg C; Atkins J; Penha RC; McKay J; Brennan P; Zhou S; Richards BJ; Yarmolinsky J; Martin RM; Borlido J; Mu XJ; Butterworth A; Shen X; Wilson J; Assimes TL; Hung RJ; Amos C; Purdue M; Rothman N; Chanock S; Travis RC; Johansson M; Mälarstig A
    Nat Commun; 2024 Apr; 15(1):3621. PubMed ID: 38684708
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. A novel pyroptosis-related gene signature exhibits distinct immune cells infiltration landscape in Wilms' tumor.
    Guo Y; Lu W; Zhang Z; Liu H; Zhang A; Zhang T; Wu Y; Li X; Yang S; Cui Q; Li Z
    BMC Pediatr; 2024 Apr; 24(1):279. PubMed ID: 38678251
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Genetic polymorphisms and clinical parameters associated with renal toxicity in Thai hematologic malignancy patients receiving high dose methotrexate.
    Pitakkitnukun P; Pongpitakmetha T; Suttichet TB; Sukkummee W; Chariyavilaskul P; Polprasert C
    Sci Rep; 2024 Apr; 14(1):9695. PubMed ID: 38678107
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Long-term functional outcomes in patients undergoing radical nephrectomy for renal cell carcinoma and tumor thrombus.
    Scilipoti P; Rosiello G; Larcher A; Fallara G; Cignoli D; Re C; Musso G; Cei F; Tian Z; Karakiewicz PI; Mottrie A; Trevisani F; Raggi D; Necchi A; Bertini R; Salonia A; Briganti A; Montorsi F; Capitanio U
    World J Urol; 2024 Apr; 42(1):264. PubMed ID: 38676733
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Radiolabelled FGF-2 for Imaging Activated Fibroblasts in the Tumor Micro-Environment.
    Bentivoglio V; Galli F; Varani M; Ranieri D; Nayak P; D'Elia A; Soluri A; Massari R; Lauri C; Signore A
    Biomolecules; 2024 Apr; 14(4):. PubMed ID: 38672507
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Squamous Cell Carcinoma Arising From Epidermal Cyst: A Case Series of 9 Patients With a Literature Review.
    Kim JY; Min S; Park JK; Kim SW
    Ann Plast Surg; 2024 May; 92(5):575-579. PubMed ID: 38669586
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Immunocompromised individuals are at increased risk of COVID-19 breakthrough infection, hospitalization, and death in the post-vaccination era: A systematic review.
    Bytyci J; Ying Y; Lee LYW
    Immun Inflamm Dis; 2024 Apr; 12(4):e1259. PubMed ID: 38661301
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Management of Nontraumatic Spontaneous Renal Hemorrhage (Wünderlich Syndrome) through Robotic-Assisted Laparoscopic Nephrectomy: A Case Series.
    Tao B; Zhang H; Zhang G; Liu H; Meng L; Zhu X; Ji X; Jia G; Qi A; Wang C
    Am J Case Rep; 2024 Apr; 25():e942826. PubMed ID: 38659203
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. MOICS, a novel classier deciphering immune heterogeneity and aid precise management of clear cell renal cell carcinoma at multiomics level.
    Liu Y; Qi L; Ye B; Wang A; Lu J; Qu L; Luo P; Wang L; Jiang A
    Cancer Biol Ther; 2024 Dec; 25(1):2345977. PubMed ID: 38659199
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Increased level of serum leucine-rich-alpha-2-glycoprotein 1 in patients with clear cell renal cell carcinoma.
    Nakanishi S; Goya M; Suda T; Yonamine T; Sugawa A; Saito S
    BMC Urol; 2024 Apr; 24(1):94. PubMed ID: 38658967
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Overexpression of cyclin F/CCNF as an independent prognostic factor for poor survival in clear cell renal cell carcinoma.
    Kwiatkowski M; Krajewski A; Durślewicz J; Buchholz K; Grzanka D; Gagat M; Zabrzyński J; Klimaszewska-Wiśniewska A
    Sci Rep; 2024 Apr; 14(1):9280. PubMed ID: 38654021
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 1731.